InternationalUSRemember you can easily switch between MIP US and MIP International at any time

IP IN CHINA: Growth & Opportunities for U.S. companies - AGENDA

   April 30, 2013 - Grand Hyatt, New York
   May 2, 2013 - Congress Plaza Hotel, Chicago




















AGENDA FOR NEW YORK:

9.00 Registration and Coffee
 

9.30 Chairman's opening remarks
Simon Crompton
, editor, Managing IP

9.40 Keynote address
Christopher Chalsen
, former Vice-Chairman, Asian Practice Committee, IPO

10.00 Opening Plenary debate: Where are things really at in terms of IP protection in China now?

  • Up-to-date experience sharing and case studies
  • What are the major challenges and frustrations currently felt by US firms in China?
  • What are the palpable improvements?
  • Extensive Q&A from floor

Janet B. Linn, chair-person, New York City Bar Association, Committee on Patent Law
Andrew Hirsch, general counsel, Fuelcor
Carmit Tujerman
, inventor and IP director, Travalo
Qinghong Xu
, partner, Lung Tin
Michelle Ma
, partner, Liu Shen
Guoxu Yang
, partner, CCPIT
Steven Duke
, economic officer, US Consulate General, Shanghai
Frederick Koenig III
, chair, SIPO/US Bar Liaison Council

11.45 Coffee

12.10 Brand protection in China: Recent cases

  • Opposition and cancellation proceedings against trademark squatters
  • Enforcement through administrative agencies
  • Multi-layer protection strategy

Ron Davis, senior director, brand protection, Qualcomm Inc
Deland Wu
, attorney at law, Lung Tin
Stephen Zou
, partner, Lung Tin
Qinghong Xu
, partner, US attorney, Lung Tin

1.10 Lunch

2.00 Keynote address
Commissioner Bruce Lehman
, chairman, IIPI

2.20 Filing patents in China: Practical guide

  • Tips for ensuring a strong and high quality patent
  • Specifics of patent requirements and examinations in China
  • SIPO update: the state of filing in China today

Mony R. Ghose, associate chief IP counsel, Becton, Dickinson & Company
Allen Tao
, partner, Liu Shen & Associates
Michelle Ma
, partner, Liu Shen & Associates

3.20 Litigating in China: Practical guide

  • Litigating as business strategy in China
  • Recent notable cases and their implications for foreign companies
  • A guide to procedure and the courts in China: How is the Chinese model similar to the German?

Jeffrey Telep, partner, King & Spalding
Steven Adkins
, partner, Allen & Overy
Guoxu Yang
, patent & trademark attorney, CCPIT
Deqiang Zhu, patent attorney, CCPIT

4.30 Coffee

4.40 Interactive roundtable:
Business culture in China

  • A history of innovation and IP in China
  • Approaches to leadership and organizational structure
  • Lost in translation? A comparative study of business culture
  • Extensive Q&A from the floor

Simon Crompton, editor, Managing IP
Gene Dorris
, CEO, Proway
Andrew Hirsch
, general counsel, Fuelcor
Commissioner Bruce Lehman
, chairman, IIPI
Steven Duke
, economic officer, US Consulate General, Shanghai

5.50 Chairman's closing remarks and end of conference

 


Supported by


     

       null 

Sponsors

      null

     null       null
profile

Managing IP

ManagingIP

ManagingIP profile

Federal Circuit’s Brunetti ruling: barring immoral or scandalous marks is unconstitutional restriction of free spee… https://t.co/MivCKFINHg

Dec 15 2017 10:12 ·  reply ·  retweet ·  favourite
ManagingIP profile

Federal Circuit rules in Amgen v Sandoz on remand from SCOTUS https://t.co/uYIkfVhCHG https://t.co/2OZAscsz32

Dec 14 2017 09:58 ·  reply ·  retweet ·  favourite
ManagingIP profile

RT @mdloney: Canada moves closer to joining the Hague Agreement with the release of proposed new Industrial Design Regulations https://t.co

Dec 12 2017 10:22 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


null null null

null null null

End of Year 2017

Tribal sovereign immunity: Taking a wrecking ball to the IPR system

The lawyer behind Allergan’s controversial transfer of patents to a Native American tribe says others are “lining up to do deals”. But, Michael Loney asks, will the PTAB rule that sovereign immunity applies in these types of deals?



Most read articles

Supplements